Effect of rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression of bone related genes and proteins in vitro

Journal of Biomedical Materials Research - Part A

Volumn 69, Issue 1, 2004, Pages 145-154

  Knabe, C ^a,b   Berger, G ^c   Gildenhaar, R ^c   Meyer, J ^d   Howlett, C R ^b   Markovic, B ^b   Zreiqat, H ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c BAM FEDERAL INSTITUTE FOR MATERIALS RESEARCH AND TESTING   (Germany)

^d R and D   (Australia)

Author keywords

Calcium phosphate cements; Calcium phosphate ceramics; Cell biomaterial interactions; Human bone derived cells; in situ hybridization

Indexed keywords

BIODEGRADATION; BIOMEDICAL ENGINEERING; CALCIUM COMPOUNDS; CELL CULTURE; GENETIC ENGINEERING; GRAFTING (CHEMICAL); GROWTH KINETICS; PHOSPHATE MINERALS; POLYSTYRENES; PROTEINS; SILICA;

CELLULAR DIFFERENTIATION; CELLULAR GROWTH;

BONE CEMENT;

ALKALINE PHOSPHATASE; BIOMATERIAL; BONE CEMENT; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; MAGNESIUM DERIVATIVE; MAGNESIUM POTASSIUM PHOSPHATE; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; POLYSTYRENE; POTASSIUM DIHYDROGEN PHOSPHATE; SIALOPROTEIN; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; AUTOGRAFT; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; BONE PROSTHESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CRYSTALLIZATION; FEMALE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; NORMAL HUMAN; OSTEOLYSIS;

EID: 1642282088     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20131     Document Type: Article

References (76)

1. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AC. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996;17: 175-185.
2. Buser D, Dula K, Hirt HP, Berthold H. Localized ridge augmentation using guided bone regeneration. In: Buser D, Dahlin C, Schenk RK, editors. Guided bone regeneration in implant dentistry. Chicago: Quintessenz; 1994. p 189-233.
3. Metsger DS, Driskell TD, Paulsrud JR. Tricalcium phosphate ceramic - a resorbable bone implant: review and current status. J Am Dent Assoc 1982;105:1035-1038. Review.
4. Hollinger JO, Brekke J, Gruskin E, Lee D. Role of bone substitutes. Clin Orthop. 1996;324:55-65. Review.
5. Ducheyne P. Bioactive calcium phosphate ceramics and glasses. In: Sedel L, Cabanela M, editors. Hip surgery: New materials and developments. London: Martin Dunitz; 1998. p 179-189.
6. Hench LL. Bioceramics. J Am Ceram Soc 1998;81:1705-1728. Review
7. Eggli PS, Muller W, Schenk RK. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. Clin Orthop Rel Res 1988;232:127-138.
8. Merten HA, Wiltfang J, Grohmann U, Hoenig JF. Intraindividual comparative animal study of alpha- and beta-tricalcium phosphate degradation in conjunction with simultaneous insertion of dental implants. J Craniofac Surg. 2001;12:59-68.
9. Wiltfang J, Merten HA, Schlegel KA, Schultze-Mosgau S, Kloss FR, Rupprecht S, Kessler P. Degradation characteristics of alpha and beta tri-calcium-phosphate (TCP) in minipigs. J Biomed Mater Res 2002;63:115-121.
10. Schliephake H, Kage T. Enhancement of bone regeneration using resorbable ceramics and a polymer-ceramic composite material. J Biomed Mater Res 2001;56:128-136.
11. Zerbo IR, Bronckers AL, de Lange GL, van Beek GJ, Burger EH. Histology of human alveolar bone regeneration with a porous tricalcium phosphate. A report of two cases. Clin Oral Implants Res 2001;12:379-384.
12. Cordioli G, Mazzocco C, Schepers E, Brugnolo E, Majzoub Z. Maxillary sinus floor augmentation using bioactive glass granules and autogenous bone with simultaneous implant placement. Clinical and histological findings. Clin Oral Implants Res 2001;12:270-278.
13. Tadjoedin ES, de Lange GL, Lyaruu DM, Kuiper L, Burger EH. High concentrations of bioactive glass material (BioGran) vs. autogenous bone for sinus floor elevation. Clin Oral Implants Res 2002;13:428-436.
14. Berger G, Gildenhaar R, Ploska U. Rapid resorbable, glassy crystalline materials on the basis of calcium alkali orthophosphates. Biomaterials 1995;16:1241-1248.
15. 2. In: Wilson J, Hench LL, Greenspan DC, editors. Bioceramics 8. Oxford: Butterworth-Heinemann; 1995. p 453-456.
16. 2. Cryst Res Tech 1994; 29:671-675.
17. Schmitz JP, Hollinger JO, Milam SB. Reconstruction of bone using calcium phosphate bone cements: A critical review. J Oral Maxillofac Surg 1999;57:1122-1126.
18. Ooms EM, Wolke JG, van de Heuvel MT, Jeschke B, Jansen JA. Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone. Biomaterials 2003;24: 989-1000.
19. Ooms EM, Wolke JG, van der Waerden JP, Jansen JA. Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J Biomed Mater Res 2002;61:9-18.
20. Khairoun I, Boltong MG, Driessens FCM, Planell JA. Effect of calcium carbonate on the compliance of an apatitic bone cement. Biomaterials 1997;18:1535-1539.
21. Khairoun I, Driessens FCM, Boltong MG, Planell JA, Wenz R. Addition of cohesion promotors to calcium phosphate cements. Biomaterials 1999;20:393-398.
22. Knabe C, Driessens FCM, Planell JA, Gildenhaar R, Berger G, Fitzner R, Radlanski R, Gross U. Evaluation of calcium phosphates and experimental bone cements using osteogenic cultures. J Biomed Mater Res 2000;52:498-508.
23. Davies JE. In vitro modelling of the bone/implant interface. Anat Rec 1996;245:426-445. Review
24. Zreiqat H, Howlett CR. Titanium substrata composition influences osteoblastic phenotype: In vitro study. J Biomed Mater Res 1999;47:360-366.
25. Zreiqat H, Markovic B, Walsh WR, Howlett CR. A novel technique for quantitative detection of mRNA expression in human bone derived cells cultured on biomaterials. J Biomed Mater Res Appl Biomater 1996;3:217-223.
26. Knabe C, Gildenhaar R, Berger G, Ostapowicz W, Fitzner R, Radlanski RJ, Gross U. In vitro investigation of novel calcium phosphates using osteogenic cultures. J Mater Sci Mater Med 1998;9:337-345.
27. Bellows CG, Aubin JE, Heersche JN, Antosz ME. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986;38:143-154.
28. Howlett CR, Evans MD, Walsh WR, Johnson G, Steele JG. Mechanism of initial attachment of cells derived from human bone to commonly used prosthetic materials during cell culture. Biomaterials 1994;15:213-222.
29. Neo M, Kotani S, Fujita Y, Nakamura T, Yamamuro T, Bando Y, Ohtsuki C, Kokubo T. Differences in ceramic-bone interface between surface-active ceramics and resorbable ceramics: a study by scanning and transmission electron microscopy. J Biomed Mater Res 1992;26:255-267.
30. Oonishi H, Hench LL, Wilson J, Sugihara F, Tsuji E, Kushitani S, Iwaki H. Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res 1999;44:31-43.
31. Ohgushi H, Okumura M, Tamai S, Shors EC, Caplan AI. Marrow cell induced osteogenesis in porous hydroxyapatite and tricalcium phosphate: a comparative histomorphometric study of ectopic bone formation. J Biomed Mater Res 1990;24:1563-1570.
32. de Bruijn JD, Bovell YP, van Blitterswijk CA. Structural arrangements at the interface between plasma sprayed calcium phosphates and bone. Biomaterials 1994;15:543-550.
33. Gross UM, Müller-Mai C, Voigt C. Comparative morphology of the bone interface with glass ceramics, hydroxyapatite, and natural coral. In: Davies JE, editor. The bone-biomaterial interface. Toronto: University of Toronto Press; 1991. p 308-320.
34. Ducheyne P, Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999;20:2287-2303. Review.
35. Schepers EJ, Ducheyne P. Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1-24 months experiment with several materials and particle sizes and size ranges. J Oral Rehab 1997;24:171-181.
36. Rodan GA, Rodan SB. Expression of the osteoblastic phenotype. In: Peck WA, editor. Bone and mineral research, vol. 2, Amsterdam: Elsevier Science; 1984. p 244-285.
37. Sodek J, Cheifitz S. Molecular regulation of osteogenesis. In: Davies JE, editor. Bone engineering. Toronto: em squared Inc.; 2000. p 31-43.
38. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143: 420-430.
39. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol 1998;76:899-910. Review.
40. Aubin JE. Osteogenic cell differentiation. In: Davies JE, editor. Bone engineering. Toronto: em squared Inc.; 2000. p 19-30.
41. Fisher LW, Termine JD. Noncollagenous proteins influencing the local mechanisms of calcification. Clin Orthop 1985;200: 362-385.
42. Sodek J, Zhang Q, Goldberg HA, Domenicucci C, Kasugai S, Wrana JL, Shapiro H, Chen J. Non-collagenous bone proteins and their role in substrate-induced bioactivity. In: Davies JE, editor. The bone-biomaterial interface. Toronto: University of Toronto Press; 1991. p 97-110.
43. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981;26:99-105.
44. Oldberg A, Franzen A, Heinegard D. The primary structure of a cell-binding bone sialoprotein. J Biol Chem 1988;263:19430-19432.
45. Malaval L, Liu F, Roche P, Aubin JE. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem 1999;74:16-27.
46. Schwartz Z, Boyan BD. Underlying mechanisms at the bone-biomaterial interface. J Cell Biochem 1994;56:340-347. Review.
47. Zreiqat H, Evans P, Howlett CR. Effect of surface chemical modification of bioceramic on phenotype of human bone-derived cells. J Biomed Mater Res 1999;44:389-396.
48. Howlett CR, Chen N, Zhang X, Akin FA, Haynes D, Hanley L, Revell P, Evans P, Zhou H, Zreiqat H. The effect of biomaterial chemistries on the osteoblastic molecular phenotype and osteogenesis: in vitro and in vivo studies. In: Davies JE, editor. Bone engineering. Toronto: em squared Inc.; 2000. p 240-255.
49. Kähari VM, Vuorio EI. Increased half-lives of procollagen mRNAs may contribute to the elevated procollagen mRNA levels in cultured scleroderma fibroblasts. Med Sci Res 1987; 15:417-418.
50. Oreffo ROC, Driessens FCM, Planell JA, Triffit JT. Growth and differentiation of human bone marrow osteoprogenitors on novel calcium phosphate cements. Biomaterials 1998;19:1845-1854.
51. Oreffo ROC, Driessens FCM, Planell JA, Triffit JT. Effects of novel calcium phosphate cements. Tissue Eng 1998;4:293-303.
52. 2. In: Sedel L, Rey C, editors. Bioceramics 10. Oxford: Butterworth-Heinemann; 1997. p 53-56.
53. Müller-Mai CM. Bioactive particulate implant materials made from glass ceramics and calcium alkali orthophosphates for bone regeneration. Habilitation thesis, Free University of Berlin, 2000.
54. Khairoun I, Magne D, Gauthier O, Bouler JM, Aguado E, Daculsi G, Weiss P. In vitro characterization and in Vivo properties of a carbonated apatite bone cement. J Biomed Mater Res 2002;6:633-642.
55. Gronowicz G, McCarthy MB. Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 1996;14:878-887.
56. Rezania A, Healy KE. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999;17:615-623.
57. Krause A, Cowles EA, Gronowicz G. Integrin-mediated signaling in osteoblasts on titanium implant materials. J Biomed Mater Res 2000;52:738-747.
58. Bates RC, Lincz LF, Burns GF. Involvement of integrins in cell survival. Cancer Metastasis Rev 1995;14:191-203. Review.
59. Yamada KM, Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 1995;7:681-689. Review.
60. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25. Review.
61. Gronthos S, Stewart K, Graves SE, Hay S, Simmons PJ. Integrin expression and function of human osteoblast-like cells. J Bone Miner Res 1997;12:1189-1197.
62. Hughes DE, Salter DM, Dedhar S, Simpson R. Integrin expression in human bone. J Bone Miner Res 1993;8:527-533.
63. Saito T, Albelda SM, Brighton CT. Identification of integrin receptors on cultured human bone cells. J Othop Res 1994;12: 384-394.
64. Shakibaei M, John T, de Souza P, Rahmanzadeh R, Merker H-J. Signal transduction by β1 integrin receptors in human chondrocytes in vitro: collaboration with IGF-I. Biochem J 1999;342: 615-623.
65. Zreiqat H, Howlett CR, Zannettino A, Evans P, Schulze-Tanzil G, Knabe C, Shakibaei M. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res 2002;62:175-184.
66. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-465.
67. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001;55:151-157.
68. Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329.
69. Ducheyne P, El-Ghannam A, Shapiro I. Effect of bioactive glass templates on osteoblast proliferation and in vitro synthesis of bone like tissue. J Cell Biochem 1994;56:162-167.
70. El-Ghannam AE, Ducheyne P, Shapiro I. Porous bioactive glass and hydroxyapatite stimulate bone cell function in vitro along different time lines. J Biomed Mater Res 1997;36:167-180.
71. Reis SA, Voigt C, Muller-Mai C, Herbst H, Bisson S, Gross U. Procollagen alpha 1(I) transcripts in cells near the interface of coralline implants in rats, detected by in situ hybridization. Clin Oral Implants Res 1996;7:253-260.
72. Neo M, Voigt CF, Herbst H, Gross UM. Analysis of osteoblast activity at biomaterial-bone interfaces by in situ hybridization. J Biomed Mater Res 1996;30:485-492.
73. Ohsawa K, Neo M, Matsuoka H, Akiyama H, Ito H, Kohno H, Nakamura T. The expression of bone matrix protein mRNAs around beta-TCP particles implanted into bone. J Biomed Mater Res 2000;52:460-466.
74. Roeser K, Johansson CB, Donath K, Albrektsson T. A new approach to demonstrate cellular activity in bone formation adjacent to implants. J Biomed Mater Res 2000;51:280-291.
75. Johansson CB, Roser K, Bolind P, Donath K, Albrektsson T. Bone-tissue formation and integration of titanium implants: an evaluation with newly developed enzyme and immunohistochemical techniques. Clin Implant Dent Relat Res 1999;1:33-40.
76. Schenk RK, Buser D, Hardwick WR, Dahlin C. Healing pattern of bone regeneration in membrane-protected defects: a histologic study in the canine mandible. Int J Oral Maxillofac Implants 1994;9:13-29.